Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Authors
Keywords
Doxorubicin, Extracellular matrix, Three-dimensional cell culture, Drug resistance
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-06
DOI
10.1186/s12885-017-3953-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro cancer cell–ECM interactions inform in vivo cancer treatment
- (2016) Andrew W. Holle et al. ADVANCED DRUG DELIVERY REVIEWS
- Evaluation of chemotherapeutics in a three-dimensional breast cancer model
- (2015) Carrie J. Lovitt et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The impact of tumor stroma on drug response in breast cancer
- (2015) Jürgen Dittmer et al. SEMINARS IN CANCER BIOLOGY
- Focal adhesion signaling and therapy resistance in cancer
- (2015) Iris Eke et al. SEMINARS IN CANCER BIOLOGY
- Miniaturized Three-Dimensional Cancer Model for Drug Evaluation
- (2013) Carrie J. Lovitt et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer
- (2013) Louisa CE Windus et al. Molecular Cancer
- Adjuvant Systemic Therapies in Breast Cancer
- (2013) Leonel F. Hernandez-Aya et al. SURGICAL CLINICS OF NORTH AMERICA
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- The Tumor Microenvironment and Strategies to Improve Drug Distribution
- (2013) Jasdeep K. Saggar et al. Frontiers in Oncology
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
- (2012) Taru Muranen et al. CANCER CELL
- Incidence and Patterns of Distant Metastases for Patients With Early-Stage Breast Cancer After Breast Conservation Treatment
- (2012) Abigail T. Berman et al. Clinical Breast Cancer
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
- (2012) Geeta Mehta et al. JOURNAL OF CONTROLLED RELEASE
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Alteration of Cellular Behavior and Response to PI3K Pathway Inhibition by Culture in 3D Collagen Gels
- (2012) Brian Fallica et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
- (2011) D. Barkan et al. CLINICAL CANCER RESEARCH
- High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
- (2010) Yi-Chung Tung et al. ANALYST
- Multicellular tumor spheroids: An underestimated tool is catching up again
- (2010) Franziska Hirschhaeuser et al. JOURNAL OF BIOTECHNOLOGY
- HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
- (2009) Britta Weigelt et al. BREAST CANCER RESEARCH AND TREATMENT
- 1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
- (2008) C. C. Park et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started